Ashfaq Ul Hassan, Ghulam Hassan, Zahida Rasool and Muneeb
Heart Diseases are a major cause of morbidity and mortality world wide. Myocardial infarction is the leading cause of congestive heart failure and death in the industrialized world. Current therapy is limited in preventing the progression of ventricular remodeling and congestive heart failure. Recent interest has focused on stem cells, which are undifferentiated and pleuropotent cells that can proliferate, potentially self-renew, and differentiate into cardiomyocytes. The article tries to underline the beneficial effects of the stem cell therapy for use in patients where other modes of therapy are not advisable and the multi purpose effects of such as therapy.
इस लेख का हिस्सा
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Telugu 